Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2

Human Gene Therapy

Volumn 13, Issue 10, 2002, Pages 1201-1211

  Lee, Joon Yung ^a,b,c   Peng, Hairong ^a,b   Usas, Arvydas ^a   Musgrave, Douglas ^a   Cummins, James ^a   Pelinkovic, Dalip ^a   Jankowski, Ron ^a   Huard, Johnny ^a,c   Ziran, Bruce ^b   Robbins, Paul ^c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, HUMAN; BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FRACTURE HEALING; FRACTURE NONUNION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; HISTOLOGY; HUMAN; HUMAN CELL; HYPOTHESIS; MOUSE; MUSCLE CELL; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PROTEIN EXPRESSION; RETROVIRUS; SCID MOUSE; SKELETAL MUSCLE; SKULL DEFECT; STEM CELL; ADULT; ANIMAL; BONE; CYTOLOGY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; MALE; METHODOLOGY; PHYSIOLOGY;

ADENOVIRIDAE; ADULT; ANIMAL; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; FRACTURE HEALING; GENE THERAPY; GENETIC VECTORS; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MUSCLE, SKELETAL; RETROVIRIDAE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSDUCTION, GENETIC; ANIMALS; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE; ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0036019199     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402320138989     Document Type: Article

References (37)

1. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells
2. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source
3. Proliferation of muscle satellite cells on intact myofibers in culture
4. The satellite cells and muscle regeneration
5. Osteoprogenitor cells within skeletal muscle
6. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation
7. Mesenchymal stem cells
8. Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo
9. Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation
10. Rapid death of injected myoblasts in myoblast transfer therapy
11. Retroviral-mediated gene transfer into hepatocytes in vivo
12. Dystrophin expression in the mdx mouse restored by stem cell transplantation
13. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration
14. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
15. Repair of craniotomy defects using bone marrow stromal cells
16. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo
17. Clonal isolation of muscle derived stem cells capable of enhancing muscle regeneration and bone healing
18. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice
19. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats
20. Ex vivo gene therapy to produce bone using different cell types
21. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2
22. Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4
23. Multilineage potential of adult human mesenchymal stem cells
24. Matching host muscle and donor myo-blasts for myosin heavy chain improves myoblast transfer therapy
25. Development of approaches to improve cell survival in myoblast transfer therapy
26. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy
27. Bone morphogenetic proteins: From basic science to clinical applications
28. The in vitro cultivation and differentiation capacities of myogenic cell lines
29. Viral vectors for gene therapy
30. Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy
31. Bone: Formation by autoinduction
32. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography
33. Gene therapy: Promises, problems and prospects
34. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer
35. Isolation of human myoblasts with the fluorescence-activated cell sorter
36. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
37. Mesenchymal stem cells reside within connective tissues of many organs